Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency

Clinical Endocrinology

Volumn 58, Issue 5, 2003, Pages 647-652

  Zenaty, Delphine ^a   Garel, Catherine ^b   Limoni, Costanzo ^c   Czernichow, Paul ^a   Léger, Juliane ^a,b  

^a St Vincent De Paul   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c UNIVERSITY OF APPLIED SCIENCES AND ARTS OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

AGE; ARTICLE; BODY MASS; CHILD; CONGENITAL DISORDER; CONTROLLED STUDY; EVALUATION; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH REGULATION; HEIGHT; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREPUBERTY; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGE FACTORS; BODY HEIGHT; BONE DEVELOPMENT; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH; HUMAN GROWTH HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFANT; MAGNETIC RESONANCE IMAGING; MALE; PUBERTY;

EID: 0038332147     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Achermann, J.C., Hamdani, K., Hindmarsh, P.C. & Brook, C.G. (1998) Birth weight influences the initial response to growth hormone treatment in growth hormone-insufficient children. Pediatrics, 102, 342-345.
2. Amselem, S. (2001) Perspectives on the molecular basis of developmental defects in the human pituitary region. In: Hypothalamic-Pituitary Development. Genetic and Clinical Aspects (eds R. Rappaport & S. Amselem), pp. 30-47. Basel: Karger.
3. Argyropoulou, M., Pérignon, F., Brunelle, F., Brauner, R. & Rappaport, R. (1991) Height of normal pituitary gland as a function of age evaluated by magnetic resonance imaging in children. Pediatric Radiology, 21, 247-249.
4. Blethen, S.L., Compton, P., Lippe, B.M., Rosenfeld, R.G., August, G.P. & Johanson, A. (1993) Factors predicting the response to growth hormone (GH) therapy in prepubertal children with GH deficiency. Journal of Clinical Endocrinology and Metabolism, 76, 574-579.
5. Bozzola, M., Adamsbaum, C., Biscaldi, I., Zecca, M., Cisternino, M., Genovese, E., Richard, I., Kalifa, G. & Chaussain, J.L. (1996) Role of magnetic resonance imaging in the diagnosis and prognosis of growth hormone deficiency. Clinical Endocrinology, 45, 21-26.
6. Cacciari, E., Tassoni, P. & Parisi, G. (1992) Pitfalls in diagnosing impaired growth hormone (GH) secretion: retesting after replacement therapy of 63 patients defined as GH-deficient. Journal of Clinical Endocrinology and Metabolism, 74, 1284-1289.
7. Carel, J.C., Ecosse, E., Nicolino, M., Tauber, M., Léger, J., Cabrol, S., Bastié-Sigeac, I., Chaussain, J.L. & Coste, J. (2002) Adult height after long-term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: observational follow-up study of the French population-based registry. British Medical Journal, 325, 70-73.
8. Chen, S., Léger, J., Garel, C., Hassan, M. & Czernichow, P (1999) Growth hormone deficiency with ectopic neurohypophysis: anatomical variations and relationship between the visibility of the pituitary stalk asserted by magnetic resonance imaging and anterior pituitary function. Journal of Clinical Endocrinology and Metabolism, 84, 2408-2413.
9. Cohen, P., Bright, G.M., Rogol, A.D., Kappelgaard, A.M. & Rosenfeld, R.G. (2002) Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. Journal of Clinical Endocrinology and Metabolism, 87, 90-98.
10. Coutant, R., Rouleau, S., Despert, F., Magontier, N., Loisel, D. & Limal, J.M. (2001) Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings. Journal of Clinical Endocrinology and Metabolism, 86, 4649-4654.
11. Fujieda, K., Hanew, K., Hirano, T., Igarashi, Y., Nishi, Y., Tachibana, K., Takano, K., Tanaka, T. & Yokoya, S. (1996) Growth response to growth hormone therapy in patients with different degrees of growth hormone deficiency. Endocrine Journal, 43 (Suppl.), 19-25.
12. GH Research Society (2000) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. Journal of Clinical Endocrinology and Metabolism, 85, 3990-3993.
13. Greulich, W.W. & Pyle, S.I. (1959) Radiographic Atlas of Skeletal Development of the Hand and the Wrist, 2nd edn. Stanford: Stanford University Press.
14. Guyda, H.J. (1999) Four decades of growth hormone therapy for short children. What have we achieved? Journal of Clinical Endocrinology and Metabolism, 84, 4307-4316.
15. Hamilton, J., Blaser, S. & Daneman, D. (1998) MR imaging in idiopathic growth hormone deficiency. American Journal of Neuroradiology, 19, 1609-1615.
16. Kornreich, L., Horev, G., Lazar, L., Josefsberg, Z. & Pertzelan, A. (1997) Magnetic resonance findings in hereditary isolated growth hormone deficiency. American Journal of Neuroradiology, 18, 1743-1747.
17. Leroy, B. & Lefort, F.A. (1971) A propos du poids et de la taille des nouveau-nés à la naissance. Revue Française de Gynécologie et Obstétrique, 66, 391-396.
18. Loche, S., Bizzarri, C., Maghnie, M., Faedda, A., Tzialla, C., Autelli, M., Casini, M.R. & Cappa, M. (2002) Results of early re-evaluation of growth hormone secretion in short children with apparent growth hormone deficiency. Journal of Pediatrics, 140, 445-449.
19. MacGillivray, M., Baptista, J. & Johanson, A. (1996) Outcome of a four-year randomized study of daily versus three times weekly somatropin treatment in prepubertal naive growth hormone-deficient children. Journal of Clinical Endocrinology and Metabolism, 81, 1806-1809.
20. Maghnie, M., Strigazzi, C., Tinelli, C., Autelli, M., Cistemino, M., Loche, S. & Severi, F. (1999) Growth hormone (GH) deficiency (GHD) of childhood onset: Reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. Journal of Clinical Endocrinology and Metabolism, 84, 1324-1328.
21. Mullis, E.P. (2000) Transcription factors in pituitary gland development and their clinical impact on phenotype. Hormone Research, 54, 107-119.
22. Netchine, I., Léger, J. & Rappaport, R. (2001) Magnetic resonance imaging of the hypothalamic-pituitary region in nontumoral hypopituitarism. In: Hypothalamic-Pituitary Development. Genetic and Clinical Aspects (eds R. Rappaport & S. Amselem), pp. 94-108. Basel: Karger.
23. Pena-Almazan, S., Buchlis, J., Miller, S., Shine, B. & Macgillivray, M. (2001) Linear growth characteristics of congenitally GH-deficient infants from birth to 1 year of age. Journal of Clinical Endocrinology and Metabolism, 86, 5691-5694.
24. Ranke, M.B., Lindberg, A., Chatelain, P., Wilton, P., Cutfield, W., Albertsson-Wikland, K. & Price, D.A. (1999) Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. Journal of Clinical Endocrinology and Metabolism, 84, 1174-1183.
25. Rappaport, R., Mugnier, E., Limoni, C., Crosnier, H., Czernichow, P., Léger, J., Limal, J.M., Rochiccioli, P. & Soskin, S. (1997) A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. Journal of Clinical Endocrinology and Metabolism, 82, 452-456.
26. Rolland-Cachera, M.F., Cole, T.J., Sempe, M., Tichet, J., Rossignol, C. & Charraud, A. (1991) Body mass index variations: centiles from birth to 87 years. European Journal of Clinical Nutrition, 45, 13-21.
27. Sempé, M., Pedron, G. & Roy-Pernot, M.P. (1970) Auxologie, méthodes et séquences. Paris: Theraplix.
28. Südfeld, H., Kiese, K., Heinecke, A. & Brämswig, J.H. (2000) Prediction of growth response in prepubertal children treated with growth hormone for idiopathic growth hormone deficiency. Acta Paediatrica, 89, 34-37.
29. Tanner, J.M., Goldstein, H. & Whitehouse, R.H. (1970) Standards for children's height at ages 2-9 years allowing for heights of parents. Archives of Diseases of Childhood, 45, 755-762.
30. Tauber, M., Moulin, P., Pienkowski, C., Jouret, B. & Rochiccioli, P. (1997) Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment. Journal of Clinical Endocrinology and Metabolism, 82, 352-356.
31. Triulzi, F., Scotti, G., Di Natale, B., Pellini, C., Lukezic, M., Scognamiglio, M. & Chiumello, G. (1994) Evidence of a congenital midline brain anomaly in pituitary dwarfs: a magnetic resonance imaging study in 101 patients. Pediatrics, 93, 409-416.
32. Vance, M.L. & Mauras, N. (1999) Growth hormone therapy in adults and children. New England Journal of Medicine, 341, 1206-1216.
33. Wasniewska, M., Arrigo, T., Cisternino, M., De Luca, F., Ghizzoni, L., Maghnie, M., Valenzise, M. & De Luca, F. (2000) Birth weight influences long-term catch up growth and height prognosis of GH-deficient children treated before the age of 2 years. European Journal of Endocrinology, 142, 460-465.